Profilo
Dr. Richard Philipson, MD, is a Chief Medical Officer at Hansa Biopharma AB and a Member at The Royal College of Physicians.
Dr. Philipson was previously employed as a Chief Medical Officer by Calliditas Therapeutics AB and a Chief Medical Officer by Trizell Ltd. He received his undergraduate degree from the University of London.
Posizioni attive di Richard Philipson
| Società | Posizione | Inizio |
|---|---|---|
| HANSA BIOPHARMA AB | Direttore Tecnico/Scientifico/R&S | 14/07/2025 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Richard Philipson
| Società | Posizione | Fine |
|---|---|---|
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Direttore Tecnico/Scientifico/R&S | 01/07/2020 |
| CALLIDITAS THERAPEUTICS AB | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Richard Philipson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
















